July 21st 2021
A key opinion leader in neurology, Arun S. Varadhachary, MD, PhD, reviews the case of a 28-year-old with spinal muscular atrophy and considers the role of nusinersen for patients with later-onset SMA.
June 7th 2021
Expert rheumatologist, Kostas N. Botsoglou, MD provides an overview of the current therapeutic landscape for Systemic Autoimmune Rheumatic Diseases (SARDs) and discusses potential treatments on the horizon.
June 4th 2021
Drs Marc P. Bonaca and Manesh R. Patel discuss the role of antiplatelet and anticoagulating agents in the treatment of patients with concurrent type 2 diabetes as per the 2021 ADA Standards of Medical Care in Diabetes.
June 3rd 2021
Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, review currently available treatment options for the management of opioid-induced constipation.
May 24th 2021
Michael R. DeBaun, MD, MPH, reviews the use of recent FDA-approved therapies along with the conventional treatment options for the management of sickle cell disease.
April 20th 2021
Recommendations for appropriate selection and use of anti-VEGF therapy for age-related macular degeneration to reduce treatment burden.
March 19th 2021
Adam Friedman, MD, FAAD provides insight into how and why insurance companies implement non-medical therapeutic switching and what healthcare providers can do to mitigate its impact on patient care.
March 12th 2021
Andrew J. Cutler, MD, and Rakesh Jain, MD, MPH, discuss current and emerging therapies for the management of attention deficit hyperactivity disorders (ADHD).
March 11th 2021
The HCPLive Insights series, “Evaluation of Spinal Muscular Atrophy in the Era of Telehealth,” put on in partnership with Cure SMA, features Diana Castro, MD, and Garey H. Noritz, MD, who offer tips and demonstrations for screening and diagnosing SMA via telehealth. Additionally, resources provided by Cure SMA are outlined for families and clinicians who suspect SMA or have a patient diagnosed with SMA.